Making it even more complicating, studies exploring the glucose-lowering mechanism of bromocriptine and cabergoline have resulted in contradictory results, while some demonstrated significant improvement in glucose metabolism independently on PRL status (25, 29, 30), others showed glucose-lowering in T2DM patients partly explained by PRL level (31). Here, PRL is linked to type 2 diabetes mellitus.